PURE EP 2.0 Study Results: From Clinical Data to Clinical Applications Nov 18, 2021 • 8:00pm - 9:00pm EDT
Conference Call to Unblind Clinical Data Collected with Signal Processing Technology for Arrhythmia Care Jul 26, 2021 • 2:30pm EDT
CEO Kenneth L. Londoner to Present at the Benzinga Biotech Small Cap Conference Mar 25, 2021 • 12:20pm EDT
BioSig to Highlight PURE EP™ System at the Benzinga Global Small Cap Conference Dec 8, 2020 • 2:30pm EDT
Conference Call to Discuss Phase 2 Human Trial of AntiViral Merimepodib Oral Solution for Treatment of COVID-19 Sep 22, 2020 • 11:00am EDT
B. Riley FBR Virtual Infectious Disease Summit - Part III: Therapeutics “Fast and Curious: Race to Finding Cures for Several Infectious Diseases, Including COVID-19” Jul 21, 2020 • 1:15pm EDT
Conference Call on Upcoming and Recent Developments for Phase II Human Clinical Trials of its Broad-Spectrum Oral Anti-viral Candidate for Treatment of COVID-19 Jun 9, 2020 • 11:00am EDT
Conference Call on Recent Developments of Subsidiary ViralClear and its Broad-Spectrum Oral Anti-Viral Candidate Merimepodib for the Treatment of COVID-19 Apr 29, 2020 • 11:00am EDT
14th Annual International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy October 11 – October 12, 2019
38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC2016) August 17 – August 20, 2016
NobleCon12 - Noble Financial Capital Markets’ Twelfth Annual Investor Conference Jan 18, 2016 • 4:00pm EDT